文献速递神经外周血管MR

MR黑血血栓成像、增强MRI与非增强MR静脉成像对脑静脉血栓的诊断价值:系统评价与荟萃分析

Diagnostic value of MR black-blood thrombus imaging, contrast-enhanced MRI, and noncontrast-enhanced MR venography in cerebral vein thrombosis: a systematic review and meta-analysis.
PubMed 文献 · Eur Radiol · 2025-08-28

系统检索至2025年3月,纳入15项研究(49个队列、1401例患者、4846个静脉节段),比较MR黑血血栓成像(MRBTI)、增强MRI(CE-MRI)与非增强MR静脉成像(NCE-MRV)诊断脑静脉血栓(CVT)的准确性。MRBTI敏感度98%、特异度99%,均显著高于CE-MRI和NCE-MRV;NCE-MRV敏感度89%高于CE-MRI的76%,但特异度89%低于CE-MRI的97%。作者认为MRBTI诊断准确性更优,尚需前瞻性多中心研究标准化方案并验证其作为独立诊断工具的可能性。

要点

  • MRBTI诊断CVT的敏感度98%、特异度99%,均显著高于CE-MRI和NCE-MRV。
  • NCE-MRV敏感度89%高于CE-MRI的76%,但特异度89%低于CE-MRI的97%。
  • 研究设计影响MRBTI和CE-MRI研究的异质性,诊断级别和扫描模式分别影响两者异质性。

核心结论

  • MRBTI对CVT的诊断准确性优于CE-MRI和NCE-MRV;尚需前瞻性多中心研究标准化MRBTI方案并验证其作为CVT独立诊断工具的可靠性。

研究设计与样本

  • 系统评价与荟萃分析,系统检索PubMed、Web of Science和Embase自建库至2025年3月,纳入评估MRBTI、CE-MRI和NCE-MRV对CVT诊断准确性的研究,共15项研究、49个队列、1401例患者、4846个静脉节段,采用双变量随机效应模型计算汇总准确性指标及95%CI,通过meta回归、亚组分析和敏感性分析探索异质性来源,采用Deeks漏斗图评估发表偏倚。

诊断标准与关键数值

  • MRBTI诊断CVT的汇总敏感度98%(95%CI:95-99%)、特异度99%(95%CI:97-100%),均显著高于CE-MRI和NCE-MRV(两者p<0.05)。
  • NCE-MRV诊断CVT的汇总敏感度89%(95%CI:78-95%)高于CE-MRI的76%(95%CI:67-83%)(p=0.045)。
  • NCE-MRV诊断CVT的汇总特异度89%(95%CI:79-94%)低于CE-MRI的97%(95%CI:93-98%)(p=0.04)。

临床应用与阅片要点

  • 作者认为MRBTI对CVT诊断准确性高,有助于更早诊断并改善患者结局。
  • 作者指出需进一步研究标准化MRBTI方案并验证其作为CVT独立诊断工具的可靠性,以优化工作流程、缩短扫描时间并提高成本效益。

局限性

  • 研究设计影响MRBTI和CE-MRI研究的异质性,诊断级别和扫描模式分别影响MRBTI和CE-MRI的异质性。
  • 需前瞻性多中心研究标准化MRBTI方案并验证其作为CVT独立诊断工具的可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The diagnosis of cerebral venous thrombosis (CVT) remains challenging due to limited consensus on the optimal imaging modality. MR black-blood thrombus imaging (MRBTI), contrast-enhanced MR imaging (CE-MRI), and noncontrast-enhanced MR venography (NCE-MRV) are promising modalities. This study aims to evaluate the performance of these modalities in diagnosing CVT.

MATERIALS AND METHODS: PubMed, Web of Science, and Embase databases were systematically searched from inception to March 2025. Studies evaluating the diagnostic accuracy of MRBTI, CE-MRI, and NCE-MRV for CVT were included. A bivariate random-effects model was used to calculate the summary accuracy metrics with 95% confidence intervals (CIs). Sources of heterogeneity were explored through meta-regression, subgroup analysis, and sensitivity analysis. Publication bias was assessed using Deeks' funnel plot.

RESULTS: Fifteen studies involving 49 cohorts (1401 patients and 4846 venous segments) were included. MRBTI achieved significantly higher sensitivity, 98% (95% CI: 95-99%), and specificity, 99% (95% CI: 97-100%) than CE-MRI and NCE-MRV (p < 0.05 for both). NCE-MRV (89%; 95% CI: 78-95%) demonstrated higher sensitivity than CE-MRI (76%; 95% CI: 67-83%) (p = 0.045), at the expense of specificity (NCE-MRV: 89%, 95% CI: 79-94%; CE-MRI: 97%, 95% CI: 93-98%; p = 0.04). Study design influenced heterogeneity in both MRBTI and CE-MRI studies, with diagnostic level and scanning mode affecting heterogeneity in MRBTI and CE-MRI, respectively.

CONCLUSION: MRBTI demonstrated superior diagnostic accuracy for CVT compared to CE-MRI and NCE-MRV. Prospective multi-center studies are required to standardize MRBTI protocols and validate its reliability as a standalone diagnostic modality for CVT.

KEY POINTS: Question The diagnostic accuracy for CVT of MRBTI, CE-MRI, and NCE-MRV remains unclear. Findings Pooled data demonstrate that MRBTI exhibits superior diagnostic performance for CVT in comparison with CE-MRI and NCE-MRV. Clinical relevance MRBTI demonstrates high diagnostic accuracy for CVT, facilitating earlier diagnosis and improving patient outcomes. Further studies should standardize MRBTI protocols and validate its reliability as a standalone diagnostic tool for CVT, thereby optimizing workflow, reducing scan time, and improving cost-effectiveness.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Li H, Hou M, Jiao Y, et al. Diagnostic value of MR black-blood thrombus imaging, contrast-enhanced MRI, and noncontrast-enhanced MR venography in cerebral vein thrombosis: a systematic review and meta-analysis. Eur Radiol. 2025. PMID: 40875017. doi:10.1007/s00330-025-11965-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。